Merit Medical Systems, Inc. (MMSI)

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Endoscopy Revenue	-	72.86M	54.77M
Endoscopy Revenue Growth	-	33.04%	48.81%
Revenue (Total)	1.54B	1.52B	1.36B
Revenue (Total) Growth	1.75%	11.75%	7.89%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Peripheral Intervention Revenue	-	579.84M	532.77M
Peripheral Intervention Revenue Growth	-	8.83%	6.08%
Cardiac Intervention Revenue	-	448.91M	368.95M
Cardiac Intervention Revenue Growth	-	21.67%	2.93%
Custom Procedural Solutions Revenue	-	209.33M	200.03M
Custom Procedural Solutions Revenue Growth	-	4.65%	2.41%
OEM Revenue	-	204.96M	199.99M
OEM Revenue Growth	-	2.48%	21.53%
Cardiovascular Revenue	-	1.44B	1.30B
Cardiovascular Revenue Growth	-	10.85%	6.65%
Revenue (Total)	1.54B	1.52B	1.36B
Revenue (Total) Growth	1.75%	11.75%	7.89%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States Revenue	922.42M	909.47M	800.78M
United States Revenue Growth	1.42%	13.57%	10.15%
International Revenue	620.01M	606.44M	555.73M
International Revenue Growth	2.24%	9.12%	4.78%
Revenue (Other)	-2.00K	4.00K	-4.00K
Revenue (Total)	1.54B	1.52B	1.36B
Revenue (Total) Growth	1.75%	11.75%	7.89%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cardiovascular Operating Income	-	166.13M	150.15M
Cardiovascular Operating Income Growth	-	10.64%	31.20%
Endoscopy Operating Income	-	18.59M	5.54M
Endoscopy Operating Income Growth	-	235.32%	-41.68%
Operating Income (Total)	187.84M	184.72M	155.69M
Operating Income (Total) Growth	1.69%	18.64%	25.62%

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 20, 2026

Data Sources Report a data error